Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
NANT provides children with high risk neuroblastoma the opportunity to receive experimental therapies for their disease when conventional, or standard therapy options have decreased. On a NANT clinical trial, the child will either receive new drugs or new drug combinations as treatment that is not available through other protocols.
